<DOC>
	<DOCNO>NCT01326598</DOCNO>
	<brief_summary>The aim present study observe glycemic control , dose requirement , hypoglycemia risk , possible adverse effect weight change , well compare parameter prior treatment patient type 2 diabetes initiate treat use V-Go circumstance close normal clinical practice possible .</brief_summary>
	<brief_title>Effectiveness V-Go™ Patients With Diabetes Real-world Setting</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Diagnosed type 2 diabetes mellitus least 12 month . 2 . Must stable treatment least month within follow diabetes medication regimen : OADs , OADs combination either exenatide , pramlintide , liraglutide ( collectively term `` incretin mimetics '' ) without receive insulin , Once twice daily injection intermediate long act insulin ( insulin NPH , insulin detemir insulin glargine ) without OADs and/or incretin . One three daily injection premix insulin ( human insulin 70/30 , insulin lispro 75/25 insulin aspart 70/30 ) without OADs and/or incretin . Any insulin therapy three insulin injection day without OADs ( MDI ) . 3 . Must willing self monitor glucose least twice day . 4 . The patient must willing able opinion investigator try VGo therapy . 5 . Age 21 80 year old , inclusive . 6 . A1C great equal 7.0 % . 1 . Acute infection fever . 2 . Serum creatinine &gt; 3.0 mg/dl metformin , metformin female creatinine &gt; 1.4 mg/dl , male creatinine &gt; 1.5 mg/dl within last 6 month . 3 . Pregnancy , intention become pregnant failure agree use adequate contraceptive measure trial female current reproductive potential.Medically acceptable contraceptive include : ( 1 ) surgical sterilization ( tubal ligation hysterectomy ) , ( 2 ) approve hormonal contraceptive ( pill , patch , implant , injection ) , ( 3 ) barrier method ( condom , diaphragm ) use spermicide , ( 4 ) intrauterine device ( IUD ) . Contraceptive measure `` Plan B™ '' , emergency use unprotected sex , acceptable method routine use . A lifestyle abstinence sexual activity acceptable mean contraception . If currently abstinent , subject must agree use doublebarrier method describe become sexually active study period . 4 . Any medical history malignant melanoma breast cancer . 5 . Medical history cancer within last five year except adequately treat basal cell carcinoma cervical carcinoma insitu . 6 . History alcohol drug abuse within last year . 7 . Any medical condition opinion investigator may preclude safe successful completion trial . 8 . Participation clinical trial involve receipt investigational drug disclose within last 30 day . 9 . Unwillingness and/or inability comply study procedure . 10 . Require regular adjustment modification basal rate 24hour period , amount insulin use meal require adjustment lessthan 2Unit increment . 11 . History hypersensitivity hyperreactivity adhesive .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>V Go™</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Insulin</keyword>
	<keyword>Oral Anti Hypoglycemic Drugs</keyword>
</DOC>